Khurana S, King LR, Manischewitz J, Posadas O, et al. Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus. Nat Med 2024 Jul 16. doi: 10.1038/s41591-024-03189.
PMID: 39013430